Results 271 to 280 of about 129,195 (289)

Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma

Annals of Oncology, 2012
Joaquim Bellmunt
exaly  

Carboplatin

Reactions Weekly, 2012
openaire   +1 more source

Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

New England Journal of Medicine, 2016
Hope S Rugo, Angela M Demichele, Christina Yau   +2 more
exaly  

Carboplatin

Reactions Weekly, 2008
openaire   +2 more sources

Carboplatin

Reactions Weekly, 2019
  +4 more sources

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial

Lancet, The, 2002
exaly  

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Lancet Oncology, The, 2013
Noriyuki Katsumata, Seiji Isonishi
exaly  

Carboplatin

Reactions Weekly, 1995
openaire   +1 more source

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

Lancet, The, 2005
exaly  

ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer

Lancet, The, 1998
exaly